Recombinant Human MMP-8 protein (His Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
His Tag
Activity
not tested
Cat no : Eg0378
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human MMP-8 protein Phe21-Gly467 (Accession# P22894) with a His tag at the C-terminus. |
GeneID | 4317 |
Accession | P22894 |
PredictedSize | 55.2 kDa |
SDS-PAGE | 60-90 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
MMP-8(Matrix metalloproteinase-8) an enzyme that degrades fibrillar collagens imparting strength to the fetal membranes, is expressed by leukocytes and chorionic cytotrophoblast cells. The high-serum MMP-8 levels (>100 ng/mL) had poor cancer-specific survival. MMP8 also has prognosis in patients with gastric cancer.
References:
1. Wang H. et al. (2004) Hum Mol Genet. 13(21):2659-69. 2. Sirniö P. et al. (2018) Br J Cancer. 119(2):213-219. 3. Laitinen A. et al. (2018) Tumour Biol. 40(9):1010428318799266. 4. Decock J. et al. (2008) BMC Cancer. 8:77. 5. Lauhio A. et al. (2011) Pharmacol Res. 64(6):590-4.